Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. Patients (n = 236) with progressive, measurable disease were randomized to three groups and received FU 2,600 ...
Phase I study of the novel anticancer drug PM00104 as a 24-hour IV infusion every 3 weeks (q3w) in patients (pts) with advanced solid tumors or lymphoma This is an ASCO Meeting Abstract from the 2009 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results